1. Home
  2. APRE vs HTOO Comparison

APRE vs HTOO Comparison

Compare APRE & HTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • HTOO
  • Stock Information
  • Founded
  • APRE 2006
  • HTOO 2020
  • Country
  • APRE United States
  • HTOO Ireland
  • Employees
  • APRE N/A
  • HTOO N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • HTOO Natural Gas Distribution
  • Sector
  • APRE Health Care
  • HTOO Utilities
  • Exchange
  • APRE Nasdaq
  • HTOO Nasdaq
  • Market Cap
  • APRE 9.4M
  • HTOO 8.8M
  • IPO Year
  • APRE 2019
  • HTOO N/A
  • Fundamental
  • Price
  • APRE $1.69
  • HTOO $4.46
  • Analyst Decision
  • APRE Strong Buy
  • HTOO
  • Analyst Count
  • APRE 1
  • HTOO 0
  • Target Price
  • APRE $20.00
  • HTOO N/A
  • AVG Volume (30 Days)
  • APRE 60.0K
  • HTOO 2.6M
  • Earning Date
  • APRE 08-12-2025
  • HTOO 01-01-0001
  • Dividend Yield
  • APRE N/A
  • HTOO N/A
  • EPS Growth
  • APRE N/A
  • HTOO N/A
  • EPS
  • APRE N/A
  • HTOO N/A
  • Revenue
  • APRE $841,012.00
  • HTOO $1,661,663.00
  • Revenue This Year
  • APRE N/A
  • HTOO $4,832.46
  • Revenue Next Year
  • APRE N/A
  • HTOO $81.82
  • P/E Ratio
  • APRE N/A
  • HTOO N/A
  • Revenue Growth
  • APRE N/A
  • HTOO N/A
  • 52 Week Low
  • APRE $1.41
  • HTOO $3.41
  • 52 Week High
  • APRE $5.01
  • HTOO $30.45
  • Technical
  • Relative Strength Index (RSI)
  • APRE 46.79
  • HTOO 40.32
  • Support Level
  • APRE $1.66
  • HTOO $4.27
  • Resistance Level
  • APRE $1.79
  • HTOO $8.55
  • Average True Range (ATR)
  • APRE 0.14
  • HTOO 0.43
  • MACD
  • APRE -0.01
  • HTOO 0.03
  • Stochastic Oscillator
  • APRE 38.89
  • HTOO 14.29

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About HTOO Fusion Fuel Green PLC

Fusion Fuel Green PLC is a provider of full-service energy engineering and advisory solutions, specializing in green hydrogen and industrial gas applications. It offers a broad portfolio of services, including the design, supply, installation, and maintenance of energy systems, as well as the transport and distribution of liquefied petroleum gas. The company serves a diverse customer base spanning commercial buildings, mixed-use developments, heavy industries, and food service sectors. The group currently derives revenue by providing comprehensive solutions for the liquefied petroleum gas (LPG) industry, which includes the supply, installation, and maintenance of LPG systems, as well as transportation and delivery of LPG in both bulk and cylinder formats.

Share on Social Networks: